Could stem cell secretions tame tough Crohn's? new trial aims to find out
NCT ID NCT07625293
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new treatment called DB-3Q for people with Crohn's disease that hasn't improved with standard therapies. DB-3Q is made from stem cells and may help reduce inflammation in the gut. The trial will enroll 36 adults and focus on safety and how well the treatment works, using a scoring system from colonoscopies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DB-3Q (a product made from stem cells that may help reduce inflammation)
What this could lead to
If successful, this could point toward a new treatment option for people with Crohn's disease that hasn't responded to other therapies.
What could go wrong
This is an early Phase 2a study with only 36 participants, so results may not apply to everyone. The treatment is still experimental and its safety and effectiveness are not yet proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University, St. Louis
St Louis, Missouri, 63110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••